Despite the widespread use of prostate-specific antigen (PSA)-based screening together with steadily evolving molecular imaging and theranostics, morbidity and mortality due to prostate cancer (PCa) remain a significant burden to the male population. Here, KLK3 is linked to posterior cortical atrophy.